Filter
98
Text search:
Licensed
pharmaceutical
products
Featured
Recommendations
7
New Publications
17
Language
Document type
No document type
37
Studies & Reports
29
Guidelines
17
Manuals
8
Strategic & Response Plan
4
Fact sheets
2
Situation Updates
1
Countries / Regions
Kenya
6
Zimbabwe
5
Ghana
4
India
4
South Africa
4
Global
4
Senegal
3
Ethiopia
3
Botswana
3
Liberia
2
Philippines
2
Tanzania
2
Rwanda
2
Malawi
2
Sierra Leone
1
Nigeria
1
Uganda
1
Nepal
1
Syria
1
Cambodia
1
Sudan
1
East and Southern Africa
1
West and Central Africa
1
Middle East and North Africa
1
South–East Asia Region
1
Western and Central Europe
1
Africa
1
Gabon
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
48
Clinical Guidelines
7
Pharmacy & Technologies
7
Public Health
5
Women & Child Health
2
Key Resources
2
Toolboxes
Pharmacy
16
AMR
15
COVID-19
12
Mental Health
4
TB
4
NTDs
2
Natural Hazards
1
HIV
1
Global Health Education
1
Caregiver
1
Malaria
1
Assessment Report
The two-year impact report for the Access to COVID-19 Tools (ACT) Accelerator details impact, case studies and timelines of key milestones for the Diagnostics, Therapeutics and Vaccines pillars, as well as the Health Systems and Response Connector.
Access to health workers who are fit for purpose, motivated and protected is a fundamental force of health service delivery and the achievement of universal health coverage and the health and health-related Sustainable Development Goals. Data and knowledge of the distribution, skill mix and future d
...
WHO and UNITAID
in collaboration with IMPAACT (International Maternal Pediatric Adolescent AIDS Clinical Trials) network, PENTA (Paediatric European Network for Treatment of AIDS) foundation and experts from the Paediatric Antiretroviral Working Group
Front. Public Health, 30 April 2021 | https://doi.org/10.3389/fpubh.2021.628744
This report presents an analysis of antibacterial agents in preclinical (third annual review) and clinical (fifth annual review) development. The analysis covers traditional (direct-acting small molecules) and non-traditional antibacterial agents in development worldwide. It evaluates to what extent
...
This report, written in partnership with various Royal Medical Colleges and Public Health England, sets out the essential actions to improve the physical health of adults with severe mental illness (SMI) across the NHS. The report makes practical recommendations for changes that will help adults wit
...
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the drug development process towards important regi
...
This document is a guide defining requirements for quality and safety for malaria rapid diagnostic testing services to safeguard the quality of the results, the safety of the operators and patients and that of the environment for use by national malaria control programmes, regulators, implementers a
...
WHO’s Country Cooperation Strategy (CCS) defines the Organization’s medium-term vision for working in and with a particular country. The CCS, developed in the context of global and national health priorities, examines the overall health situation in a country, including the state of the health s
...
The Global Strategy for Tuberculosis Research and Innovation will support the efforts of governments and other stakeholders to accelerate TB research and innovation, and improve equitable access to the benefits of research.
Availabl in Arabic, Chinese, English, French, Spanish and Russian
The prevalence, availability, and use of antimalarial medicines (AMLs) were studied in six Cambodian provinces along the Thai-Cambodian border. The study was divided into two parts: the first looked at the quality of AMLs available in Pursat, Pailin, Battambang, Bantey Meanchey, Oddar Meanchey, and
...
Rwanda’s fourth health sector strategic plan (HSSP4) is meant to provide the health sector with a Strategic Plan that will highlight its commitments and priorities for the coming 6 years. It will be fully integrated in the overall economic development plan of the Government. HSSP4 will fulfill the
...
Antimicrobial resistance (AMR) is described as a situation when bacteria, viruses, fungi and parasites
change over time and no longer respond to medicines, making infections harder or impossible to treat,
and increasing the risk of disease spread, severe illness and death.1 AMR in recent years has
...
